全文获取类型
收费全文 | 1270454篇 |
免费 | 99819篇 |
国内免费 | 1981篇 |
专业分类
耳鼻咽喉 | 18407篇 |
儿科学 | 44305篇 |
妇产科学 | 35024篇 |
基础医学 | 181035篇 |
口腔科学 | 33563篇 |
临床医学 | 110666篇 |
内科学 | 256236篇 |
皮肤病学 | 28012篇 |
神经病学 | 99793篇 |
特种医学 | 51190篇 |
外国民族医学 | 660篇 |
外科学 | 195875篇 |
综合类 | 27026篇 |
现状与发展 | 1篇 |
一般理论 | 377篇 |
预防医学 | 95182篇 |
眼科学 | 27796篇 |
药学 | 94541篇 |
2篇 | |
中国医学 | 2336篇 |
肿瘤学 | 70227篇 |
出版年
2018年 | 13155篇 |
2017年 | 9973篇 |
2016年 | 10912篇 |
2015年 | 12381篇 |
2014年 | 17184篇 |
2013年 | 26238篇 |
2012年 | 36057篇 |
2011年 | 38092篇 |
2010年 | 22828篇 |
2009年 | 21845篇 |
2008年 | 36682篇 |
2007年 | 39292篇 |
2006年 | 39543篇 |
2005年 | 38472篇 |
2004年 | 37644篇 |
2003年 | 36378篇 |
2002年 | 35732篇 |
2001年 | 63915篇 |
2000年 | 66347篇 |
1999年 | 56079篇 |
1998年 | 14362篇 |
1997年 | 12999篇 |
1996年 | 13413篇 |
1995年 | 13391篇 |
1994年 | 12721篇 |
1993年 | 11730篇 |
1992年 | 44514篇 |
1991年 | 43461篇 |
1990年 | 42202篇 |
1989年 | 40091篇 |
1988年 | 36875篇 |
1987年 | 36220篇 |
1986年 | 33600篇 |
1985年 | 32268篇 |
1984年 | 24119篇 |
1983年 | 20216篇 |
1982年 | 11683篇 |
1981年 | 10639篇 |
1980年 | 9460篇 |
1979年 | 21301篇 |
1978年 | 14785篇 |
1977年 | 12489篇 |
1976年 | 11668篇 |
1975年 | 12603篇 |
1974年 | 14643篇 |
1973年 | 14103篇 |
1972年 | 12938篇 |
1971年 | 11714篇 |
1970年 | 11039篇 |
1969年 | 10012篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Rozhkov V. P. Trifonov M. I. Soroko S. I. 《Neuroscience and behavioral physiology》2022,52(3):383-394
Neuroscience and Behavioral Physiology - We present here results from analysis of the formation of brain bioelectrical activity in children and adolescents living in the northern region of Russia... 相似文献
2.
3.
4.
5.
6.
Laurien J. Zeverijn Eleonora J. Looze Subotheni Thavaneswaran J. Maxime van Berge Henegouwen Robert J. Simes Louisa R. Hoes Katrin M. Sjoquist Hanneke van der Wijngaart Lucille Sebastian Birgit S. Geurts Chee K. Lee Gijsbrecht F. de Wit David Espinoza Paul Roepman Frank P. Lin Anne M. L. Jansen Wendy W. J. de Leng Vincent van der Noort Lindsay V. M. Leek Filip Y. F. L. de Vos Carla M. L. van Herpen Hans Gelderblom Henk M. W. Verheul David M. Thomas Emile E. Voest 《International journal of cancer. Journal international du cancer》2023,153(7):1413-1422
The Dutch Drug Rediscovery Protocol (DRUP) and the Australian Cancer Molecular Screening and Therapeutic (MoST) Program are similar nonrandomized, multidrug, pan-cancer trial platforms that aim to identify signals of clinical activity of molecularly matched targeted therapies or immunotherapies outside their approved indications. Here, we report results for advanced or metastatic cancer patients with tumors harboring cyclin D-CDK4/6 pathway alterations treated with CDK4/6 inhibitors palbociclib or ribociclib. We included adult patients that had therapy-refractory solid malignancies with the following alterations: amplifications of CDK4, CDK6, CCND1, CCND2 or CCND3, or complete loss of CDKN2A or SMARCA4. Within MoST, all patients were treated with palbociclib, whereas in DRUP, palbociclib and ribociclib were assigned to different cohorts (defined by tumor type and alteration). The primary endpoint for this combined analysis was clinical benefit, defined as confirmed objective response or stable disease ≥16 weeks. We treated 139 patients with a broad variety of tumor types; 116 with palbociclib and 23 with ribociclib. In 112 evaluable patients, the objective response rate was 0% and clinical benefit rate at 16 weeks was 15%. Median progression-free survival was 4 months (95% CI: 3-5 months), and median overall survival 5 months (95% CI: 4-6 months). In conclusion, only limited clinical activity of palbociclib and ribociclib monotherapy in patients with pretreated cancers harboring cyclin D-CDK4/6 pathway alterations was observed. Our findings indicate that monotherapy use of palbociclib or ribociclib is not recommended and that merging data of two similar precision oncology trials is feasible. 相似文献
7.
Medicine, Health Care and Philosophy - In this paper, I will provide a phenomenological analysis of somatic obsessions at times present in obsessive–compulsive disorder. I will compare two... 相似文献
8.
9.
Kyung-Suk Suh Suk Kyun Hong Sola Lee Su young Hong Sanggyun Suh Eui Soo Han Seong-Mi Yang YoungRok Choi Nam-Joon Yi Kwang-Woong Lee 《American journal of transplantation》2022,22(1):260-265
Minimally invasive approaches are increasingly being applied in surgeries and have recently been used in living donor hepatectomy. We have developed a safe and reproducible method for minimally invasive living donor liver transplantation, which consists of pure laparoscopic explant hepatectomy and pure laparoscopic implantation of the graft, which was inserted through a suprapubic incision. Pure laparoscopic explant hepatectomy without liver fragmentation was performed in a 60-year-old man with alcoholic liver cirrhosis and hepatocellular carcinoma. The explanted liver was retrieved through a suprapubic incision. A modified right liver graft, procured from his 24-year-old son using the pure laparoscopic method, was inserted through a suprapubic incision, and implantation was performed intracorporeally throughout the procedure. The time required to remove the liver was 369 min, and the total operative time was 960 min. No complications occurred during or after the surgery. The patient recovered well, and his hospital stay was of 11 days. Pure laparoscopic living donor liver transplantation from explant hepatectomy to implantation was performed successfully. It is a feasible procedure when performed by a highly experienced surgeon and transplantation team. Further studies with larger sample sizes are needed to confirm its safety and feasibility.
10.